A novel neutralizing monoclonal antibody against cell-binding polypeptide of ricin

Hybridoma

Volumn 24, Issue 5, 2005, Pages 263-266

  Guo, Jian Wei ^a,b   Shen, Bei Fen ^a   Feng, Jian Nan ^a   Sun, Ying Xun ^a   Yu, Ming ^a   Hu, Mei Ru ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Jincheng Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3E1; NEUTRALIZING ANTIBODY; RICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; BIOLOGICAL WARFARE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG SYNTHESIS; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; WESTERN BLOTTING;

ANIMALIA;

EID: 27144531007     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2005.24.263     Document Type: Article

References (14)

1. Lord JM, Roberts LM, and Robertus JD: Ricin: structure, mode of action, and some current applications. FASEB J 1984;8:201-208.
2. Endo Y, Mitsui K, Motiguki M, and Tsurugi K: The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J Biol Chem 1987;262:5908-5912.
3. Maddaloni M, Cooke C, Wilkinson R, Stout AV, Eng L, and Pincus SH: Immunological characteristics associated with the protective efficacy of antibodies to ricin. J Immunol 2004;172:6221-6228.
4. Colombatti M, Johnson VG, Skopicki HA, Fendley B, Lewis MS, and Youle RJ: Identification and characterization of monoclonal antibody recognizing a galactose-binding domain of the toxin ricin. J Immunol 1987;138:3339.
5. Olsnes S, and Pihl A: Toxic lectins and related proteins. In: Molecular Action of Toxins and Viruses. Cohen P, and van Heyningen S (Eds.). Elsevier/North Holland, Amsterdam, 1982, pp. 51-105
6. Foxwell BM, Detre SI, Donva TA, and Thorpe PE: The use of antiricin antibodies to protect mice intoxicated with ricin. Toxicology 1985;34:79-88.
7. Youle RJ, and Colombatti M: Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol. J Biol Chem 1987;262:4676-4682.
8. Faseks de St. G, and Scheidegger D: Production of monoclonal antibodies-strategy and tactics. J Immun Methods 1980;35:1-21.
9. Nelson PN: Generating monoclonal antibody probes and techniques for characterizing and localizing reactivity to antigenic determinants. In: Epitope Mapping. Practical Approach. Westwood OMR, and Hay FC (Eds.). Oxford University Press, Oxford, 2001, pp. 159-197.
10. Huges JN, Lindsay CD, and Griffiths GD: Morphology of ricin and abrin exposed endothelial cells is consistent with apoptotic cell death. Hum Exp Toxicol 1996;15:443-451.
11. Furukawa-Stoffer TL, Mah DC, Cherwonogrodzky JW, and Weselake RJ: A novel biological-based assay for the screening of neutralizing antibodies to ricin. Hybridoma 1999;18:505-511.
12. Chanh TC, Romanowski MJ, and Hewetson JF: Monoclonal antibody prophylaxis against the in vivo toxicity of ricin in mice. Immunol Invest 1993;22:63-72.
13. Olsnes S, and Pihl A: Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis. Biochemistry 1973;12:3121.
14. Medina BF, Wright R, Funk V, Sentz D, Barroso L, Wilkins TD, Petri WJ, and Cramer CL: A non-toxic lectin for antigen delivery of plant-based mucosal vaccines. Vaccine 2003;21:997-1005.